Benefits and risks of anticoagulation resumption following traumatic brain injury

JAMA Internal Medicine

Volumn 174, Issue 8, 2014, Pages 1244-1251

  Albrecht, Jennifer S ^a   Liu, Xinggang ^a   Baumgarten, Mona ^b   Langenberg, Patricia ^b   Rattinger, Gail B ^c   Smith, Gordon S ^b   Gambert, Steven R ^b   Gottlieb, Stephen S ^b   Zuckerman, Ilene H ^a,b,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c FAIRLEIGH DICKINSON UNIVERSITY   (United States)

^d IMPAQ International LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

ADRENAL HEMORRHAGE; AGED; ALZHEIMER DISEASE; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING DISORDER; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COHORT ANALYSIS; COMORBIDITY; DEEP VEIN THROMBOSIS; DEMENTIA; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; THROMBOSIS; TRAUMATIC BRAIN INJURY; UPPER GASTROINTESTINAL BLEEDING; VALVULAR HEART DISEASE; ADRENAL DISEASE; ATRIAL FIBRILLATION; BLEEDING; BRAIN INJURY; CHEMICALLY INDUCED; COMPLICATION; GASTROINTESTINAL HEMORRHAGE; MYOCARDIAL INFARCTION; PULMONARY EMBOLISM; RISK ASSESSMENT; STROKE; VENOUS THROMBOSIS; VERY ELDERLY;

ADRENAL GLAND DISEASES; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; BRAIN INJURIES; BRAIN ISCHEMIA; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMORRHAGE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MYOCARDIAL INFARCTION; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE; THROMBOSIS; VENOUS THROMBOSIS; WARFARIN;

EID: 84905851581     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2014.2534     Document Type: Article

References (39)

1. Faul M, Xu L,Wald MM, Coronado V. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths, 2002-2006. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2010.
2. Denson K, Morgan D, Cunningham R, et al. Incidence of venous thromboembolism in patients with traumatic brain injury. Am J Surg. 2007;193(3): 380-384.
3. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331(24): 1601-1606.
4. Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS. Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg. 2004;240(3): 490-498.
5. Chen YH, Kang JH, Lin HC. Patients with traumatic brain injury: population-based study suggests increased risk of stroke. Stroke. 2011;42 (10): 2733-2739.
6. Albrecht JS, Liu X, Smith GS, et al. Stroke incidence following traumatic brain injury in older adults. J Head Trauma Rehabil. In press.
7. Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group. J Trauma. 2002;53(1): 142-164.
8. Levy AS, Salottolo K, Bar-Or R, et al. Pharmacologic thromboprophylaxis is a risk factor for hemorrhage progression in a subset of patients with traumatic brain injury. J Trauma. 2010;68(4): 886-894.
9. Bratton SL, Chestnut RM, Ghajar J, et al; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS/CNS. Guidelines for the management of severe traumatic brain injury. V. deep vein thrombosis prophylaxis. J Neurotrauma. 2007;24(S1)(suppl 1): S32-S36.
10. Keeling D, Baglin T, Tait C, et al; British Committee for Standards in Haematology. Guidelines on oral anticoagulation with warfarin-fourth edition. Br J Haematol. 2011;154 (3): 311-324.
11. Scudday T, Brasel K,Webb T, et al. Safety and efficacy of prophylactic anticoagulation in patients with traumatic brain injury. J AmColl Surg. 2011;213 (1): 148-154.
12. Phelan HA. Pharmacologic venous thromboembolism prophylaxis after traumatic brain injury: a critical literature review. J Neurotrauma. 2012;29(10): 1821-1828.
13. Carlile M, Nicewander D, Yablon SA, et al. Prophylaxis for venous thromboembolism during rehabilitation for traumatic brain injury: a multicenter observational study. J Trauma. 2010; 68(4): 916-923.
14. Salottolo K, Offner P, Levy AS, Mains CW, Slone DS, Bar-Or D. Interrupted pharmocologic thromboprophylaxis increases venous thromboembolism in traumatic brain injury. J Trauma. 2011;70(1): 19-26.
15. Koehler DM, Shipman J, Davidson MA, Guillamondegui O. Is early venous thromboembolism prophylaxis safe in trauma patients with intracranial hemorrhage. J Trauma. 2011;70(2): 324-329.
16. Thurman DJ, Sniezek JE, Johnson D, et al. Guidelines for Surveillance of Central Nervous System Injury. Atlanta, GA: Centers for Disease Control and Prevention; 1995.
17. Marr A, Coronado V, eds. Central Nervous System Injury Surveillance Data Submission Standards-2002. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2004.
18. Carroll CP, Cochran JA, Guse CE,Wang MC. Are we underestimating the burden of traumatic brain injury? surveillance of severe traumatic brain injury using Centers for Disease Control International Classification of Disease, Ninth Revision, Clinical Modification, traumatic brain injury codes. Neurosurgery. 2012;71(6): 1064-1070.
19. Langlois JA, Rutland-BrownW, Thomas KE. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations, and Deaths. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2004. http://www.cdc.gov/ncipc/pub-res/TBI-in-US- 04/TBI-USA-Book- Oct1.pdf. Accessed May 2, 2014.
20. Coronado VG, Thomas KE, Kegler SR; Centers for Disease Control and Prevention. Rates of hospitalization related to traumatic brain injury-nine states, 2003. MMWR Morb Mortal Wkly Rep. 2007;56(8): 167-170.
21. Wahl PM, Rodgers K, Schneeweiss S, et al. Validation of claims-based diagnostic and procedure codes for cardiovascular and gastrointestinal serious adverse events in a commercially-insured population. Pharmacoepidemiol Drug Saf. 2010;19(6): 596-603.
22. Arnason T,Wells PS, vanWalraven C, Forster AJ. Accuracy of coding for possible warfarin complications in hospital discharge abstracts. Thromb Res. 2006;118(2): 253-262.
23. Jasuja GK, Reisman JI,Miller DR, et al. Identifying major hemorrhage with automated data: results of the Veterans Affairs study to improve anticoagulation (VARIA). Thromb Res. 2013;131(1): 31-36.
24. Maletis GB, InacioMCS, Reynolds S, Funahashi TT. Incidence of symptomatic venous thromboembolism after elective knee arthroscopy. J Bone Joint Surg Am. 2012;94(8): 714-720.
25. Centers for Medicare and Medicaid Services Chronic Condition DataWarehouse. Condition Categories. http://www.ccwdata.org/web/guest/condition- categories. Accessed October 25, 2013.
26. Gage BF,Waterman AD, ShannonW, Boechler M, RichMW, RadfordMJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22): 2864-2870.
27. Gage BF, Yan Y,Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006;151(3): 713-719.
28. Allison PD. 1995. Survival Analysis Using SAS: A Practical Guide. Cary, NC: SAS Institute.
29. Hernán MA, Hernández-Díaz S, Robins JM. A structural approach to selection bias. Epidemiology. 2004;15(5): 615-625.
30. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med. 1990; 323(22): 1505-1511.
31. Singer DE, Albers GW, Dalen JE, et al; American College of Chest Physicians. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008;133(6) (suppl): 546S-592S.
32. Björck S, Palaszewski B, Friberg L, Bergfeldt L. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke. 2013; 44(11): 3103-3108.
33. Ahmad O, Ahmad KE, Dear KBG, Harvey I, Hughes A, Lueck CJ. Atrial fibrillation and anticoagulation in a stroke unit population. Intern Med J. 2009;39(11): 752-756.
34. Agarwal S, Bennett D, Smith DJ. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting. Am J Cardiovasc Drugs. 2010;10 (1): 37-48.
35. Pugh D, Pugh J, Mead GE. Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review. Age Ageing. 2011; 40(6): 675-683.
36. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation. 2013;127(1): e6-e245.
37. Garwood CL, Corbett TL. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls. Ann Pharmacother. 2008;42(4): 523-532.
38. Gage BF, Birman-Deych E, Kerzner R, Radford MJ, Nilasena DS, RichMW. Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Am J Med. 2005;118(6): 612-617.
39. Witt DM, Delate T, Garcia DA, et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med. 2012;172(19): 1484-1491.